Anticipated Shortage

PIPERACILLIN AND TAZOBACTAM FOR INJECTION

SANDOZ CANADA INCORPORATED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of PIPERACILLIN AND TAZOBACTAM FOR INJECTION in Canada?

A shortage of PIPERACILLIN AND TAZOBACTAM FOR INJECTION 0.5G 4G is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 21, 2026), but it has not started yet.

Why is PIPERACILLIN AND TAZOBACTAM FOR INJECTION not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will PIPERACILLIN AND TAZOBACTAM FOR INJECTION be available again?

The estimated resolution date (September 25, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusAnticipated Shortage

Same-ingredient products on fileNone found

Affected strength0.5G 4G

Last updated2026-09-21

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

DIN

02299658

Strength

0.5G 4G

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

TAZOBACTAM PIPERACILLIN

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-09-21

Anticipated Shortage

Disruption of the manufacture of the drug.

2026-09-21

Resolved

Disruption of the manufacture of the drug.

2026-09-02

Resolved

Disruption of the manufacture of the drug.

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

ACLASTA

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495929